Drug Trial Radar · NCT03560986
Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)
Last checked: Nov 19, 2026Latest source record: Aug 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
267
Actual
Start
May 31, 2018
Primary completion
Aug 1, 2019
Study completion Aug 1, 2019
Sponsor
- Lead sponsor
- Grünenthal GmbHIndustry
- Sponsor type
- Industry
- First posted
- Jun 19, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial was to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS). The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A consisting of 4 infusions (neridronic acid 100 mg or placebo) over 10 days, and a Follow-up Period 1 until Week 26. At Week 26, participants meeting the pre-specified criteria entered the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days and follow-up visits until Week 52. Participants not meeting the pre-specified criteria to continue into Treatment Period B continued in Follow-up Period 2 until Week 52.
Conditions
- Complex Regional Pain Syndrome (CRPS)
Interventions
Neridronic acid 100 mgDrug
100 mg neridronic acid supplied in glass vials in 8 mL of excipients.
PlaceboDrug
Glass vials with matching placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 12 in the Average Pain Intensity Score (Weekly Average of Pain Values Recorded Daily in the Electronic Diary)Time frame: From the Baseline Phase (Day -7 to Day -1) to Week 12
Locations
71 sites in 7 countries. Site status is shown where the registry gives one.
US446 - Clinical Trial Connection
Cottonwood, Arizona
US453 - Physicians Research Group II, LLC
Tempe, Arizona
US428 - Quality of Life Medical and Research Center LLC
Tucson, Arizona
US422 - Woodland International Research Group
Little Rock, Arkansas
US454 - Alliance Research Institute
Canoga Park, California
US415 - Clearview Medical Research LLC
Canyon Country, California
US410 - Alliance Research Centers
Laguna Hills, California
US432 - Torrance Clinical Research Institute Inc.
Lomita, California
Us414 - Alexander Ford Md
Los Angeles, California
US441 - Samaritan Center for Medical Research
Los Gatos, California
US406 - CI Trials
Santa Ana, California
US411 - Syrentis Clinical Research
Santa Ana, California
US420 - Mountain View Clinical Research, INC
Denver, Colorado
US447 - ASCLEPES Research Centers
Brooksville, Florida
US457 - Florida Spine Institute
Clearwater, Florida
US430 - South Lake Pain Institute
Clermont, Florida
US434 - Finlay Medical Research
Miami, Florida
US407 - Oceane 7 Medical and Research Center, Inc.
Miami, Florida
US436 - Cordova Research Institute
Miami, Florida
US417 - Tampa Pain Relief Center
Tampa, Florida
US403 - Palm Beach Research Center
West Palm Beach, Florida
US404 - Infinite Clinical Trials
Riverdale, Georgia
US424 - Georgia Neurology and Sleep Medicine Assoc.
Suwanee, Georgia
US431 - Injury Care Research, LLC
Boise, Idaho
US437 - Great Lakes Clinical Trials LLC
Chicago, Illinois
US435 - Centex Studies Inc
Lake Charles, Louisiana
US448 - The Center for Rheumatology and Bone Research
Wheaton, Maryland
US450 - SRI International
Plymouth, Michigan
US449 - Michigan Pain Consultants
Wyoming, Michigan
US433 - Creighton University - Osteoporosis Research Center
Omaha, Nebraska
US419 - Manhattan Behavioral Medicine
New York, New York
US440 - OnSite Clinical Solutions LLC
Charlotte, North Carolina
US405 - OnSite Clinical Solutions LLC
Hickory, North Carolina
US416 - Medical Research International
Oklahoma City, Oklahoma
US429 - Lehigh Valley Health
Allentown, Pennsylvania
US438 - Abington Neurological Associates, LTD.
Willow Grove, Pennsylvania
US425 - PCPMG Clinical Research Unit LLC
Greenville, South Carolina
US423 - Biopharma Informatic Inc. Research Center
Houston, Texas
US443 - Centex Studies Inc
Houston, Texas
US421 - Northwest Clinical Research Center
Bellevue, Washington
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.